From: Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma
Immunophenotype
Total (%)
CK
36 (100)
CK5/6
13 (36.1)
CK7
23 (63.9)
Vimentin
TTF-1
P63
17 (47.2)